Search by Drug Name or NDC
NDC 68788-6797-06 Ciclopirox 80 mg/mL Details
Ciclopirox 80 mg/mL
Ciclopirox is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is CICLOPIROX.
MedlinePlus Drug Summary
Ciclopirox topical solution is used along with regular nail trimming to treat fungal infections of the fingernails and toenails (an infection that may cause nail discoloration, splitting and pain). Ciclopirox is in a class of medications called antifungals. It works by stopping the growth of nail fungus.
Related Packages: 68788-6797-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ciclopirox Topical
Product Information
| NDC | 68788-6797 |
|---|---|
| Product ID | 68788-6797_456d24ee-f6f5-4103-b3ae-abebab35f4aa |
| Associated GPIs | 90150030002020 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Ciclopirox |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ciclopirox |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 80 |
| Active Ingredient Units | mg/mL |
| Substance Name | CICLOPIROX |
| Labeler Name | Preferred Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077623 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68788-6797-06 (68788679706)
| NDC Package Code | 68788-6797-6 |
|---|---|
| Billing NDC | 68788679706 |
| Package | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68788-6797-6) / 6.6 mL in 1 BOTTLE, WITH APPLICATOR |
| Marketing Start Date | 2016-11-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |